Alternatives to Granata Bio Corporation

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

AI-powered platform for personalized cell therapy development and manufacturing.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Global marketplace connecting researchers with human biospecimens for life science research.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

AI-powered platform for antibody discovery and development to create new medicines.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.